Owens-Illinois (OI) has been under a strong bear grip, hence the stock is down -5.42% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.11% in the past 1 week. The stock has risen by 0.61% in the past week indicating that the buyers are active at lower levels, but the stock is down -5.54% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 2.08% and the 50-Day Moving Average is 0.78%.The 200 Day SMA reached 5.75%. Owens-Illinois, Inc. has dropped 9.93% during the last 3-month period . Year-to-Date the stock performance stands at 3.67%.
Owens-Illinois (NYSE:OI): After opening at $17.95, the stock dipped to an intraday low of $17.87 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $18.09 and the buying power remained strong till the end. The stock closed at $18.06 for the day, a gain of 1.57% for the day session. The total traded volume was 733,460. The stocks close on the previous trading day was $17.78.
Owens-Illinois, Inc. is the manufacturer of glass containers. The Company has approximately 75 glass manufacturing plants in over 21 countries. Its product lines include glass containers for the food and beverage industries. The Company operates in four segments: Europe, North America, South America and Asia Pacific. The Europe segment primarily produces glass containers for beer, wine, champagne, spirits and food markets. The North America segment has glass container manufacturing plants in the United States and Canada. The South America segment primarily produces glass containers for beer, non-alcoholic beverages, spirits, flavored malt beverages, wine, food and pharmaceuticals markets. The Asia Pacific segment primarily produces glass containers for the beer, wine, food and non-alcoholic beverage markets. The Company also produces glass packaging for a variety of food items, soft drinks, teas, juices and pharmaceuticals.